No evidence for XMRV in German CFS and MS patients with fatigue despite the ability of the virus to infect human blood cells in vitroLack of evidence for xenotropic murine leukemia virus-related virus(XMRV) in German prostate cancer patientsUnsung Hero Robert C. GalloHigh Virus Loads in Naturally and Experimentally SIVagm-Infected African Green MonkeysRetroelements and the human genome: new perspectives on an old relationPDZ Domain-mediated interaction of interleukin-16 precursor proteins with myosin phosphatase targeting subunitsIdentification of the protease cleavage sites in a reconstituted Gag polyprotein of an HERV-K(HML-2) elementReconstitution of the ancestral glycoprotein of human endogenous retrovirus k and modulation of its functional activity by truncation of the cytoplasmic domainVaccine protection against lethal homologous and heterologous challenge using recombinant AAV vectors expressing codon-optimized genes from pandemic swine origin influenza virus (SOIV).Immunological changes in simian immunodeficiency virus (SIV(agm))-infected African green monkeys (AGM): expanded cytotoxic T lymphocyte, natural killer and B cell subsets in the natural host of SIV(agm).Joint production of prime/boost pairs of Fowlpox Virus and Modified Vaccinia Ankara recombinants carrying the same transgene.The evolutionary dynamics of human endogenous retroviral families.Beneficial and detrimental effects of human endogenous retroviruses.Induction of neutralizing antibodies specific for the envelope proteins of the koala retrovirus by immunization with recombinant proteins or with DNA.The role of the immune response during SIVagm infection of the African green monkey natural host.Aspects of risk assessment and risk management of nosocomial transmission of classical and variant Creutzfeldt-Jakob disease with special attention to German regulations.Public health and civil liberties. Introduction to the talking point on public health versus civil liberties.Genetic alterations of the long terminal repeat of an ecotropic porcine endogenous retrovirus during passage in human cells.Staufen-1 interacts with the human endogenous retrovirus family HERV-K(HML-2) rec and gag proteins and increases virion production.Characterisation of a human cell-adapted porcine endogenous retrovirus PERV-A/C.The Rec protein of HERV-K(HML-2) upregulates androgen receptor activity by binding to the human small glutamine-rich tetratricopeptide repeat protein (hSGT).Regulation of human endogenous retrovirus-K expression in melanomas by CpG methylation.Increased neutralizing antibody response after simultaneous immunization with leucogen and the feline leukemia virus transmembrane protein.Molecular cloning and functional characterization of the human endogenous retrovirus K113.Transspecies transmission of the endogenous koala retrovirus.Expression of human endogenous retrovirus K in melanomas and melanoma cell lines.Porcine endogenous retroviruses PERV-A and PERV-B infect neither mouse cells in vitro nor SCID mice in vivo.Suppressing active replication of a live attenuated simian immunodeficiency virus vaccine does not abrogate protection from challenge.Human endogenous retrovirus HERV-K113 is capable of producing intact viral particles.A novel small animal model to study the replication of simian foamy virus in vivo.Induction of anti-simian immunodeficiency virus cellular and humoral immune responses in rhesus macaques by peptide immunogens: correlation of CTL activity and reduction of cell-associated but not plasma virus load following challenge.Inhibition of porcine endogenous retroviruses by RNA interference: increasing the safety of xenotransplantation.Generation of neutralising antibodies against porcine endogenous retroviruses (PERVs).Immunization with the transmembrane protein of a retrovirus, feline leukemia virus: absence of antigenemia following challenge.Enhanced T- and B-cell responses to simian immunodeficiency virus (SIV)agm, SIVmac and human immunodeficiency virus type 1 Gag DNA immunization and identification of novel T-cell epitopes in mice via codon optimization.Failure to detect Borna disease virus antigen and RNA in human blood.Antibodies neutralizing feline leukaemia virus (FeLV) in cats immunized with the transmembrane envelope protein p15E.Vaccine development using the simian immunodeficiency virus model for AIDS.Reconstitution, age estimation and expression of the Human Endogenous Retrovirus K113 with its original sequence present at the time of integration.No in vivo infection of triple immunosuppressed non-human primates after inoculation with high titers of porcine endogenous retroviruses.
P50
Q21135591-50E53B65-FEE5-41E2-A368-2B8C91BF0D48Q21245049-4DA50F89-3965-4B3B-B278-E5095ABABA4DQ22065525-E7C7BB8A-1E60-420D-938B-8F57D93E27DFQ22252842-0D4F8B4B-96A9-4647-A122-2FBF3CE05879Q24563781-1D58EE10-FCF6-42CF-B9E2-5FCD738D3FF6Q28202144-27D484FF-A7B8-40BC-936E-1BFAA03F99DDQ28743663-C6593966-FB06-428F-9DF0-3337BE0B379EQ28749689-37426C20-E22C-4AD0-9104-433E8A28A396Q30398001-12453C9B-A98C-4063-9DA0-07B0466095FCQ34113917-80924C2A-CE31-419F-9E2C-A1C99E08ECBEQ34171896-CCF2BE9F-38F3-492F-AD68-D17ECBB72214Q34530194-CC626B53-30A9-4C19-B56B-DA13F134389FQ35005902-0E00660D-0E9D-4C9F-8EC6-9B6C48FEE473Q35599403-56CDEC6F-FD54-4A21-9372-E2F597ED5EE4Q35650881-CE94697F-ADB0-4621-A17A-FBDFA12D0CAEQ35743227-E0975B9D-D8AB-4D0B-AFF1-7135E6DABE68Q36495086-8B9C2BE0-A922-4671-848B-FE85AE8F6092Q38970313-899D2C70-C3AE-4F07-A2EB-70928EE038C1Q39113570-32FF44CC-B86A-4C9A-B8A3-52F2F437984EQ39121785-CAF0474A-2244-4290-B03D-9F0FAA4C099BQ39325220-457E995B-55F2-4F81-B7C2-42F4B4234E9FQ39749080-7238F9D7-51C8-4339-A7A6-4EAA2499DFFEQ39839274-3F1AB6A1-DF3B-4B3B-BB75-093CA90DDCDAQ40036193-49185C98-4320-4F4C-87E0-A2C25EB6D647Q40280108-6FA1686A-A193-4AE5-A116-9292CC950136Q40421149-7E44328D-A864-4C39-97D5-CF955CBA3F06Q40438545-0C1D618C-79F1-4C44-912F-1D4A619B855BQ40864765-E0159414-8AA8-4F0B-B4BD-4BBFBB60E276Q42030768-6B7C2147-F884-4649-A72F-428679AF9A69Q42237778-9CC21F81-2BCB-4B47-9A4D-B634F6812715Q43830379-2334842C-2756-49C0-91BA-835788CEEA0DQ44362972-E0450FD6-0688-4D53-A681-D8361B1C89A2Q44666638-92A55339-682F-4766-BFBA-03E36AD83F2CQ45371002-4E19BEC8-883E-488B-81C7-EA8839DAC7D4Q45382961-BB73451D-D7C4-413D-9D41-7F10EAEB89E0Q45414847-D07F396A-C336-43BD-82B9-2765F5A3E2E8Q45420692-25C1C1CF-6F2F-45AE-AB8D-8D1EB5A94782Q45729270-1BC3950F-8895-4833-B3D5-5A623D657BF2Q46043946-0FD958E3-000B-4C7C-B064-6EE552C988D6Q46109073-DDB3710B-02F7-43D0-A23B-90A6FED53F6B
P50
description
Duits viroloog (1942-2014)
@nl
German virologist
@en
deutscher Virologe und Mediziner
@de
virólogo alemán
@es
virólogu alemán (1942–2014)
@ast
عالم فيروسات ألماني
@ar
name
Reinhard Kurth
@ast
Reinhard Kurth
@ca
Reinhard Kurth
@cy
Reinhard Kurth
@da
Reinhard Kurth
@de
Reinhard Kurth
@en
Reinhard Kurth
@es
Reinhard Kurth
@fr
Reinhard Kurth
@nb
Reinhard Kurth
@nl
type
label
Reinhard Kurth
@ast
Reinhard Kurth
@ca
Reinhard Kurth
@cy
Reinhard Kurth
@da
Reinhard Kurth
@de
Reinhard Kurth
@en
Reinhard Kurth
@es
Reinhard Kurth
@fr
Reinhard Kurth
@nb
Reinhard Kurth
@nl
prefLabel
Reinhard Kurth
@ast
Reinhard Kurth
@ca
Reinhard Kurth
@cy
Reinhard Kurth
@da
Reinhard Kurth
@de
Reinhard Kurth
@en
Reinhard Kurth
@es
Reinhard Kurth
@fr
Reinhard Kurth
@nb
Reinhard Kurth
@nl
P1006
P1015
P214
P227
P244
P268
P269
P5361
P1006
P1015
P106
P1207
n2010122173
P1284
00000024530